Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Are Medical Professionals Divided on Cannabis and Anxiety Treatment for Panic Disorder? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

The clinician debate on cannabis for anxiety highlights differing opinions among healthcare providers regarding its role in managing panic disorder. Examining professional disagreement, risk-benefit views, and ongoing clinical controversy provides clarity on why consensus is limited. Understanding the clinician debate on cannabis for anxiety helps patients navigate treatment options safely under professional guidance. 

Medical Cannabis UK

Exploring Professional Divisions 

Analysing the clinician debate on cannabis for anxiety ensures that patients and providers consider both benefits and risks before integrating cannabis into care plans. 

Professional Disagreement 

Professional disagreement stems from varying interpretations of current evidence, personal clinical experience, and differing comfort levels with cannabinoid therapy. 

Risk-Benefit Views 

Risk-benefit views weigh potential relief from panic symptoms against adverse effects, dependency concerns, and long-term safety. 

Clinical Controversy 

Clinical controversy persists due to limited high-quality studies, inconsistent outcomes, and the novelty of cannabis-based interventions in mainstream practice. 

In conclusion, the clinician debate on cannabis for anxiety reflects a cautious but evolving landscape. Considering professional disagreement, risk-benefit views, and clinical controversy helps patients make informed decisions while working closely with healthcare providers. 

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories